HGEN.AX vs. CURE.AX

Last updated Jul 16, 2026

HGEN.AX (Global X Hydrogen ETF) and CURE.AX (Global X S&P Biotech ETF) are both exchange-traded funds - HGEN.AX is a Global Equities fund tracking the Global X Hydrogen Index, while CURE.AX is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 3 years, HGEN.AX returned 12.54%/yr vs 21.60%/yr for CURE.AX. At a 0.40 correlation, their price movements are largely independent.

Performance

HGEN.AX vs. CURE.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Global X Hydrogen ETF (HGEN.AX) and Global X S&P Biotech ETF (CURE.AX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HGEN.AX achieves a 43.83% return, which is significantly higher than CURE.AX's 22.66% return.

HGEN.AX

• 1D: -3.10%
• 1M: -14.66%
• 6M: 13.86%
• YTD: 43.83%
• 1Y: 92.59%
• 3Y*: 12.54%
• 5Y*: —
• 10Y*: —

CURE.AX

• 1D: 0.58%
• 1M: 17.05%
• 6M: 20.39%
• YTD: 22.66%
• 1Y: 65.69%
• 3Y*: 21.60%
• 5Y*: 5.62%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HGEN.AX vs. CURE.AX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
HGEN.AX Global X Hydrogen ETF	43.83%	43.64%	-10.40%	-20.10%	-36.18%	7.90%
CURE.AX Global X S&P Biotech ETF	22.66%	25.25%	8.13%	10.63%	-22.98%	-8.10%

Correlation

The correlation between HGEN.AX and CURE.AX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.34
Correlation (All Time) Calculated using the full available price history since Oct 6, 2021	0.40

Over the past year, the correlation between HGEN.AX and CURE.AX has dropped to 0.19 - well below their long-term average of 0.40, suggesting their price drivers have been diverging.

Return for Risk

HGEN.AX vs. CURE.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HGEN.AX

HGEN.AX Risk / Return Rank: 71
HGEN.AX Sharpe Ratio Rank: 76
HGEN.AX Sortino Ratio Rank: 67
HGEN.AX Omega Ratio Rank: 63
HGEN.AX Calmar Ratio Rank: 83
HGEN.AX Martin Ratio Rank: 67

CURE.AX

CURE.AX Risk / Return Rank: 90
CURE.AX Sharpe Ratio Rank: 92
CURE.AX Sortino Ratio Rank: 90
CURE.AX Omega Ratio Rank: 87
CURE.AX Calmar Ratio Rank: 95
CURE.AX Martin Ratio Rank: 87

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HGEN.AX vs. CURE.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Hydrogen ETF (HGEN.AX) and Global X S&P Biotech ETF (CURE.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HGEN.AX	CURE.AX	Difference
Sharpe ratio: Return per unit of total volatility	1.94	2.62	-0.68
Sortino ratio: Return per unit of downside risk	2.50	3.46	-0.96
Omega ratio: Gain probability vs. loss probability	1.31	1.43	-0.11
Calmar ratio: Return relative to maximum drawdown	3.61	5.80	-2.19
Martin ratio: Return relative to average drawdown	9.67	14.61	-4.95

HGEN.AX vs. CURE.AX - Sharpe Ratio Comparison

The current HGEN.AX Sharpe Ratio is 1.94, which is comparable to the CURE.AX Sharpe Ratio of 2.62. The chart below compares the historical Sharpe Ratios of HGEN.AX and CURE.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HGEN.AX vs. CURE.AX - Drawdown Comparison

The maximum HGEN.AX drawdown since its inception was -72.54%, which is greater than CURE.AX's maximum drawdown of -59.81%. Use the drawdown chart below to compare losses from any high point for HGEN.AX and CURE.AX.

Drawdown Indicators

	HGEN.AX	CURE.AX	Difference
Max Drawdown Largest peak-to-trough decline	-72.54%	-59.81%	-12.73%
Max Drawdown (1Y) Largest decline over 1 year	-25.14%	-11.68%	-13.46%
Max Drawdown (3Y) Largest decline over 3 years	-49.84%	-28.37%	-21.47%
Max Drawdown (5Y) Largest decline over 5 years	—	-50.92%	—
Current Drawdown Current decline from peak	-25.22%	-5.45%	-19.77%
Average Drawdown Average peak-to-trough decline	-47.63%	-27.38%	-20.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.50%	4.66%	+4.84%

Volatility

HGEN.AX vs. CURE.AX - Volatility Comparison

Global X Hydrogen ETF (HGEN.AX) has a higher volatility of 13.18% compared to Global X S&P Biotech ETF (CURE.AX) at 9.67%. This indicates that HGEN.AX's price experiences larger fluctuations and is considered to be riskier than CURE.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HGEN.AX	CURE.AX	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.18%	9.67%	+3.51%
Volatility (6M) Calculated over the trailing 6-month period	32.95%	21.01%	+11.94%
Volatility (1Y) Calculated over the trailing 1-year period	46.74%	25.95%	+20.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.64%	30.91%	+5.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.64%	31.70%	+4.94%

Dividends

HGEN.AX vs. CURE.AX - Dividend Comparison

HGEN.AX's dividend yield for the trailing twelve months is around 0.78%, while CURE.AX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
CURE.AX Global X S&P Biotech ETF	0.00%	0.00%	0.00%	0.00%	0.06%	11.64%	9.47%	2.05%
HGEN.AX Global X Hydrogen ETF	0.78%	0.34%	0.60%	0.17%	0.09%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both HGEN.AX and CURE.AX in my portfolio?

HGEN.AX and CURE.AX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

What is the main difference between HGEN.AX and CURE.AX?

HGEN.AX is categorized as Global Equities, while CURE.AX is Health & Biotech Equities. HGEN.AX tracks Global X Hydrogen Index, while CURE.AX tracks S&P Biotechnology Select Industry Index.